Impact of systematic lymphadenectomy at the time of interval debulking surgery on the survival of patients with advanced-stage epithelial ovarian carcinoma following neoadjuvant chemotherapy

被引：0
|
作者：
Nasioudis, Dimitrios [1 ]
Mastroyannis, Spyridon [1 ]
Latif, Nawar [1 ]
Haggerty, Ashley [1 ]
Cory, Lori [1 ]
Giuntoli, Robert [1 ]
Kim, Sarah [1 ]
Morgan, Mark [1 ]
Ko, Emily [1 ]
机构：
[1] Penn Med, Philadelphia, PA USA
来源：
GYNECOLOGIC ONCOLOGY | 2021年 / 162卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
344
引用
收藏
页码：S184 / S184
页数：1
相关论文
共 50 条
  • [31] Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Ce Bian
    Kui Yao
    Li Li
    Tao Yi
    Xia Zhao
    Archives of Gynecology and Obstetrics, 2016, 293 : 163 - 168
  • [32] Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Bian, Ce
    Yao, Kui
    Li, Li
    Yi, Tao
    Zhao, Xia
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (01) : 163 - 168
  • [33] Does the time interval off neoadjuvant chemotherapy before and after interval debulking surgery affect the overall survival of women with advanced-epithelial ovarian cancer?
    Clark, M.
    Lee, Y.
    Xu, W.
    Brown, T.
    May, T.
    GYNECOLOGIC ONCOLOGY, 2018, 149 : 92 - 92
  • [34] Risk factors for septic adverse events and their impact on survival in advanced ovarian cancer patients treated with neoadjuvant chemotherapy and interval debulking surgery
    Son, Joo-Hyuk
    Lee, Joo-Hyung
    Jung, Jung-Ah
    Kong, Tae-Wook
    Paek, Jiheum
    Chang, Suk-Joon
    Ryu, Hee-Sug
    GYNECOLOGIC ONCOLOGY, 2018, 151 (01) : 32 - 38
  • [35] Should neoadjuvant chemotherapy be preferred to an alternative treatment for advanced ovarian cancer: Comparison of neoadjuvant chemotherapy followed by interval debulking surgery and primary debulking surgery in patients with advanced ovarian cancer
    Liu, J.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 176 - 176
  • [36] Postoperative survival analysis of laparotomy versus robotic interval debulking in epithelial ovarian cancer patients following neoadjuvant chemotherapy
    Paraghamian, S. E.
    Staley, A.
    Tucker, K.
    Zhang, Y.
    Wang, M.
    Clark, L. H.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 148 - 148
  • [37] Impact of neoadjuvant chemotherapy cycles prior to interval surgery in patients with advanced epithelial ovarian cancer
    Colombo, P. E.
    Labaki, M.
    Fabbro, M.
    Bertrand, M.
    Mourregot, A.
    Gutowski, M.
    Saint-Aubert, B.
    Quenet, F.
    Rouanet, P.
    Mollevi, C.
    GYNECOLOGIC ONCOLOGY, 2014, 135 (02) : 223 - 230
  • [38] Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma
    Gockley, Allison Ann
    Fiascone, Stephen
    Courant, Katherine Hicks
    Pepin, Kristen
    Del Carmen, Marcela
    Clark, Rachel M.
    Goldberg, Joel
    Horowitz, Neil
    Berkowitz, Ross
    Worley, Michael, Jr.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 (03) : 585 - 592
  • [39] Impact of the Time Interval Between Primary Debulking Surgery and Start of Adjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer
    Lin, Hao
    Chen, Wen-Hsin
    Wu, Chen-Hsuan
    Ou, Yu-Che
    Chen, Yu-Jen
    Chen, Ying-Yi
    Lin, Yu-Han
    Fu, Hung-Chun
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 5413 - 5422
  • [40] Neoadjuvant chemotherapy followed by interval debulking surgery versus primary debulking surgery in the advanced epithelial ovarian cancer - a retrospective cohort study
    Maricic, Slobodan
    Mandic, Aljosa
    Dejanovic, Ninoslav
    Kladar, Nebojsa
    Popovic, Marina
    Ivkovic-Kapicl, Tatjana
    Gutic, Bojana
    Kokanov, Dunja
    VOJNOSANITETSKI PREGLED, 2021, 78 (11) : 1193 - 1199
12345